| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.15▲ | 0.15▲ | 0.15▼ | 0.16▼ | 0.16▼ |
| MA10 | 0.15▼ | 0.15▼ | 0.15▼ | 0.16▼ | 0.19▼ |
| MA20 | 0.15▼ | 0.15▼ | 0.15▼ | 0.17▼ | 0.42▼ |
| MA50 | 0.15▼ | 0.15▼ | 0.16▼ | 0.20▼ | 0.48▼ |
| MA100 | 0.15▼ | 0.16▼ | 0.16▼ | 0.46▼ | 0.89▼ |
| MA200 | 0.16▼ | 0.17▼ | 0.17▼ | 0.49▼ | 2.45▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.000▼ | 0.000▲ | 0.003▲ | -0.025▼ |
| RSI | 49.407▼ | 48.874▼ | 46.872▼ | 40.981▼ | 34.116▼ |
| STOCH | 49.064 | 48.269 | 66.646 | 17.269▼ | 13.321▼ |
| WILL %R | -41.573 | -41.573 | -53.982 | -90.526▼ | -96.681▼ |
| CCI | -10.675 | -8.226 | -57.184 | -119.784▼ | -66.380 |
|
Tuesday, March 24, 2026 04:54 PM
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, ...
|
|
Tuesday, March 24, 2026 08:50 AM
On March 23, 2026, BioAtla reconvened a special shareholder meeting originally convened on March 2, 2026, with approximately 68% of outstanding common shares represented in person virtually or by ...
|
|
Monday, March 02, 2026 04:30 AM
SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- BioAtla, Inc. (BCAB) (NASDAQ: BCAB or the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/03/26 | 0.1482 | 0.1534 | 0.1482 | 0.1534 | 213,496 |
| 30/03/26 | 0.161 | 0.1615 | 0.153 | 0.154 | 608,871 |
| 27/03/26 | 0.156 | 0.169 | 0.1506 | 0.1532 | 821,365 |
| 26/03/26 | 0.1543 | 0.17 | 0.15 | 0.17 | 747,826 |
| 25/03/26 | 0.1488 | 0.1664 | 0.1488 | 0.1581 | 904,656 |
| 24/03/26 | 0.17 | 0.17 | 0.148 | 0.1481 | 2,425,891 |
| 23/03/26 | 0.1623 | 0.178 | 0.1617 | 0.17 | 813,879 |
| 20/03/26 | 0.157 | 0.1686 | 0.157 | 0.1686 | 947,890 |
| 19/03/26 | 0.16 | 0.1684 | 0.1526 | 0.1563 | 940,881 |
| 18/03/26 | 0.17 | 0.1749 | 0.16 | 0.16 | 1,541,080 |
|
|
||||
|
|
||||
|
|